Concepedia

P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer

Sasmit Sarangi, Ambarish Pandey, Anne‐Laure Papa, Poulomi Sengupta, Jawahar Kopparam, Ushashi C. Dadwal, Sudipta Basu, Shiladitya Sengupta

Medical Oncology · 2013 · 28 citations · 13 references

DOI

Concepts

References

13

Paraneoplastic Thrombocytosis in Ovarian Cancer

Rebecca L. Stone, Alpa M. Nick, Iain A. McNeish et al. · New England Journal of Medicine · 2012 · 822 citations · Full text

, , +13

Purines, Purinergic Receptors, and Cancer

Cancer Research · 2012 · 291 citations

, , +16

Docetaxel–cisplatin might be superior to docetaxel–capecitabine in the first-line treatment of metastatic triple-negative breast cancer

Yun Fan, Binghe Xu, Peng Yuan et al. · Annals of Oncology · 2012 · 87 citations · Full text

, , +15

Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools.

Eliezer Rapaport, J. Fontaine · Proceedings of the National Academy of Sciences · 1989 · 82 citations · Full text

, , +17

Triple-Negative Breast Cancer: Current State of the Art

Francesca Rastelli, Sandra Biancanelli, Amalia Falzetta et al. · Tumori Journal · 2010 · 71 citations

, , +13